Speakers

Lung-I Cheng

Vice President, Cell and Gene Therapy • AmerisourceBergen

Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.

He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.

Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.

Also Speaking

Jenny Holt

Senior Vice President, Programme and Portfolio Management • Ray Therapeutics

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific

Eric Hacherl

Vice President, Head of Manufacturing • Spark Therapeutics

Also Speaking

Image

2025 Downloadable Agenda

Download the post-event report for Advanced Therapies Week 2024.
Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.